Skip to content
akaturk Academic measurement
Sign in Sign up

Article detail · 2022 · article

A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU

Journal International Journal of Pharmaceutics
ISSN0378-5173
YÖKSİS OpenAlex
Year2022
Citations23OpenAlex
Citations23Semantic Scholar
Percentile%78.2
FWCI1.391.00 = world average
Scopus (SJR)Q1
WoS (JCR)Q1
DOI10.1016/j.ijpharm.2022.121940 OpenAlexOpenAlex record

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueInternational Journal of Pharmaceutics
  • Catalog match (ISSN)International Journal of Pharmaceutics
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

23citationsOpenAlex · cited_by_count (cache / database)

7 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2023 Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal CancerCitations 13 · OpenAlex
  2. 2023 Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal CancerCitations 13 · OpenAlex
  3. 2023 Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer.Citations 12 · OpenAlex
  4. 2023 Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal CancerCitations 12 · OpenAlex
  5. 2024 Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin LymphomaCitations 4 · OpenAlex
  6. 2024 Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin LymphomaCitations 2 · OpenAlex
  7. 2024 Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin LymphomaCitations 2 · OpenAlex

Authors

7
  1. Safiye Akkın 1
  2. GAMZE VARAN 2
  3. DAVUT AKSÜT 3
  4. Milo Malanga 4
  5. AYŞE ERCAN 5
  6. MURAT ŞEN 6
  7. EREM BİLENSOY HACETTEPE ÜNİVERSİTESİ 7